A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether etrasimod is a safe and effective treatment
for moderately to severely active ulcerative colitis.
Condition or disease: Ulcerative Colitis Intervention/treatment: Drug: Etrasimod Drug:
Placebo Phase: Phase 3